Tamar Peretz Selected Research

antigen CYFRA21.1

10/2015	The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
11/2009	The diagnostic and prognostic value of ProGRP in lung cancer.
10/2009	The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: a pilot study.
6/2002	Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tamar Peretz Research Topics

Disease

81	Neoplasms (Cancer) 03/2022 - 04/2002
44	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2002
20	Melanoma (Melanoma, Malignant) 01/2020 - 10/2003
15	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2002
7	Carcinogenesis 01/2019 - 12/2003
7	Carcinoma (Carcinomatosis) 08/2016 - 06/2002
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 04/2011
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 04/2011
4	Lung Neoplasms (Lung Cancer) 11/2019 - 11/2009
4	Inflammation (Inflammations) 10/2019 - 05/2006
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 06/2007
3	Triple Negative Breast Neoplasms 02/2021 - 08/2014
3	Head and Neck Neoplasms (Head and Neck Cancer) 08/2016 - 02/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2015 - 01/2006
3	Urinary Bladder Neoplasms (Bladder Cancer) 10/2009 - 06/2002
2	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2018
2	Disease Progression 01/2018 - 11/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2016 - 08/2010
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2016 - 11/2009
2	Hypersensitivity (Allergy) 01/2016 - 05/2006
2	Sarcoma (Soft Tissue Sarcoma) 07/2015 - 08/2002
2	Hypertension (High Blood Pressure) 03/2015 - 03/2013
2	Heart Failure 03/2015 - 01/2012
2	Necrosis 01/2013 - 01/2010
2	Adenocarcinoma 08/2011 - 11/2006
2	Ovarian Neoplasms (Ovarian Cancer) 03/2011 - 08/2005
2	Microsatellite Instability 01/2009 - 01/2008
2	Prostatic Neoplasms (Prostate Cancer) 02/2008 - 02/2005
2	Choriocarcinoma 04/2005 - 10/2003
1	Cognitive Dysfunction 03/2022
1	Carcinoma in Situ 01/2022
1	Cachexia 01/2021
1	Stomatitis 01/2021
1	Weight Gain 01/2021
1	Pathologic Processes 01/2021

Drug/Important Bio-Agent (IBA)

17	heparanaseIBA 10/2019 - 04/2002
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2009
10	EnzymesIBA 01/2019 - 10/2003
9	Proteins (Proteins, Gene)FDA Link 07/2018 - 07/2004
8	Peptides (Polypeptides)IBA 02/2016 - 07/2004
8	Estrogen ReceptorsIBA 01/2014 - 12/2003
7	Pharmaceutical PreparationsIBA 01/2021 - 08/2002
7	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2009
6	Hormones (Hormone)IBA 01/2022 - 08/2002
6	thymidine kinase 1IBA 01/2022 - 01/2010
6	Heparitin Sulfate (Heparan Sulfate)IBA 10/2019 - 07/2007
6	AntigensIBA 10/2016 - 07/2004
5	Estrogens (Estrogen)FDA Link 10/2019 - 12/2003
5	Cisplatin (Platino)FDA LinkGeneric 05/2018 - 09/2006
4	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2015
4	Messenger RNA (mRNA)IBA 01/2020 - 12/2003
4	VaccinesIBA 10/2016 - 08/2009
4	antigen CYFRA21.1IBA 10/2015 - 06/2002
4	Fluorouracil (Carac)FDA LinkGeneric 03/2015 - 10/2002
4	Tamoxifen FDA LinkGeneric 07/2007 - 05/2002
3	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2019
3	Thyroid HormonesIBA 01/2022 - 11/2020
3	Phenobarbital (Luminal)FDA Link 10/2018 - 01/2018
3	big gastrinIBA 02/2016 - 01/2006
3	pro-gastrin-releasing peptide (31-98)IBA 02/2016 - 01/2006
3	Small Interfering RNA (siRNA)IBA 07/2014 - 08/2004
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2020
2	GlucuronidaseIBA 10/2019 - 02/2008
2	Keratins (Keratin)IBA 01/2018 - 06/2007
2	Indicators and Reagents (Reagents)IBA 01/2016 - 11/2006
2	IpilimumabIBA 12/2015 - 10/2012
2	Gemcitabine FDA Link 07/2015 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 11/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2015 - 03/2003
2	Bevacizumab (Avastin)FDA Link 03/2015 - 03/2013
2	CytokinesIBA 12/2014 - 02/2010
2	Interleukin-6 (Interleukin 6)IBA 12/2014 - 02/2010
2	Peptide Hydrolases (Proteases)FDA Link 07/2014 - 05/2012
2	ParaffinIBA 01/2014 - 02/2012
2	Tyrosine (L-Tyrosine)FDA Link 04/2013 - 03/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2013 - 01/2010
2	Transcription Factors (Transcription Factor)IBA 11/2012 - 04/2011
2	Phosphopyruvate Hydratase (Enolase)IBA 11/2009 - 01/2006
2	Keratin-19 (Keratin 19)IBA 10/2009 - 06/2002
2	Neoplasm Antigens (Tumor Antigens)IBA 08/2009 - 01/2006
2	EpitopesIBA 11/2007 - 07/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2003 - 10/2002
1	methyl methanethiosulfonate (MMTS)IBA 01/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 02/2021
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2021
1	human ERBB2 proteinIBA 01/2021
1	RetinoidsIBA 11/2020
1	RNA Splicing FactorsIBA 01/2020
1	RNA Precursors (Precursor, mRNA)IBA 01/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	Platinum Compounds (Compounds, Platinum)IBA 11/2019
1	PlatinumIBA 11/2019

Therapy/Procedure

30	Therapeutics 03/2022 - 04/2006
18	Drug Therapy (Chemotherapy) 01/2021 - 03/2003
11	Immunotherapy 01/2021 - 06/2002
4	Adjuvant Chemotherapy 01/2014 - 10/2002
3	Radiotherapy 01/2012 - 02/2010
2	Nephrectomy 04/2016 - 08/2010
1	Cognitive Training 03/2022
1	Salvage Therapy 01/2020